Oxytocin-augmented social cognitive skills training in schizophrenia

Neuropsychopharmacology

Volumn 39, Issue 9, 2014, Pages 2070-2077

  Davis, Michael C ^a,b   Green, Michael F ^a,b   Lee, Junghee ^a,b   Horan, William P ^a,b   Senturk, Damla ^c   Clarke, Angelika D ^a,b   Marder, Stephen R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Education   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PLACEBO; CENTRAL NERVOUS SYSTEM AGENTS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMPATHY; FEMALE; FOLLOW UP; HUMAN; LEARNING; MALE; OUTPATIENT CARE; PARALLEL DESIGN; PERCEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; SCHIZOPHRENIA; SOCIAL COGNITION; COGNITION; COGNITIVE THERAPY; DOUBLE BLIND PROCEDURE; FACIAL EXPRESSION; INTRANASAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PATTERN RECOGNITION; PROCEDURES; PSYCHOLOGY; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADULT; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EMPATHY; FACIAL EXPRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; OXYTOCIN; PATTERN RECOGNITION, VISUAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL PERCEPTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904503938     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.68     Document Type: Article

References (42)

1. Averbeck BB (2010). Oxytocin and the salience of social cues. Proc Natl Acad Sci USA 107: 9033-9034.
2. Averbeck BB, Bobin T, Evans S, Shergill SS (2011). Emotion recognition and oxytocin in patients with schizophrenia. Psychol Med 42: 259-266.
3. Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A et al (2010). Oxytocin selectively improves empathic accuracy. Psychol Sci 21: 1426-1428.
4. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514-516.
5. Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS (2011). Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS ONE 6: e27237.
6. Davis MC, Lee J, Horan WP, Clarke AD, McGee MR, Green MF et al (2013). Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res 147: 393-397.
7. Ekman P, Friesen WV (1976). Pictures of Facial Affect. Consulting Psychologists Press: Palo Alto, CA.
8. Feifel D, Macdonald K, Cobb P, Minassian A (2012). Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophr Res 139: 207-210.
9. Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B et al (2010). Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68: 678-680.
10. Fischer-Shofty M, Brune M, Ebert A, Shefet D, Levkovitz Y, Shamay-Tsoory SG (2013). Improving social perception in schizophrenia: the role of oxytocin. Schizophr Res 146: 357-362.
11. Goldman MB, Gomes AM, Carter CS, Lee R (2011). Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology 216: 101-110.
12. Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L, Grunder G et al (2013). Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol Psychiatry 74: 172-179.
13. Guastella AJ, Mitchell PB, Dadds MR (2008). Oxytocin increases gaze to the eye region of human faces. Biol Psychiatry 63: 3-5.
14. Horan W, Kern R, Tripp C, Hellemann G, Wynn JK, Bell M et al (2011a). Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res 45: 1113-1122.
15. Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K et al (2012). Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull 38: 865-872.
16. Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF (2009). Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res 107: 47-54.
17. Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M et al (2011b). Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res 45: 1113-1122.
18. Insel TR, Fernald RD (2004). How the brain processes social information: searching for the social brain. Annu Rev Neurosci 27: 697-722.
19. Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP (2013). The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry 170: 165-172.
20. Kurtz MM, Richardson CL (2012). Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophr Bull 38: 1092-1104.
21. Lee J, Zaki J, Harvey P, Ochsner K, Green M (2011). Schizophrenia patients are impaired in empathic accuracy. Psychol Med 41: 2297.
22. Lee MR, Wehring HJ, McMahon RP, Linthicum J, Cascella N, Liu F et al (2013). Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Schizophr Res 145: 110-115.
23. Leknes S, Wessberg J, Ellingsen DM, Chelnokova O, Olausson H, Laeng B (2012). Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions. Soc Cogn Affect Neurosci 8: 741-749.
24. Mayer JD, Salovey P, Caruso DR, Sitarenios G (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion 3: 97-105.
25. McDonald S, Flanagan S, Rollins J, Kinch J (2003). TASIT: a new clinical tool for assessing social perception after traumatic brain injury. J Head Trauma Rehabil 18: 219-238.
26. Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M et al (2013). Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, doubleblind, placebo-controlled study. CNS Drugs 27: 57-65.
27. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD et al (2008). The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165: 203-213.
28. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rep 10: 799-812.
29. Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW (2013). Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 500: 458-462.
30. Pedersen CA, Gibson CM, Rau SW, Salimi K, Smedley KL, Casey RL et al (2011). Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res 132: 50-53.
31. Penn DL, Corrigan PW, Bentall RP, Racenstein JM, Newman L (1997). Social cognition in schizophrenia. Psychol Bull 121: 114-132.
32. Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD (2013). The Social Cognition Psychometric Evaluation Study: Results of the Expert Survey and RAND Panel. Schizophr Bull, 31 May 2013 (Epub ahead of print).
33. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA et al (2011). The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry 168: 1266-1277.
34. Prehn K, Kazzer P, Lischke A, Heinrichs M, Herpertz SC, Domes G (2013). Effects of intranasal oxytocin on pupil dilation indicate increased salience of socioaffective stimuli. Psychophysiology 50: 528-537.
35. Roberts DL, Penn DL (2009). Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res 166: 141-147.
36. Rosenthal R, Hall JA, DiMatteo MR, Rogers PL, Archer D (1979). Sensitivity to nonverbal communication: the PONS test. Johns Hopkins University Press: Baltimore.
37. Smith MJ, Horan WP, Cobia DJ, Karpouzian TM, Fox JM, Reilly JL et al (2013). Performance-Based Empathy Mediates the Influence of Working Memory on Social Competence in Schizophrenia. Schizophr Bull, 31 December 2013 (Epub ahead of print).
38. Smith MJ, Horan WP, Karpouzian TM, Abram SV, Cobia DJ, Csernansky JG (2012). Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia. Schizophr Res 137: 196-202.
39. Statucka M, Walder DJ (2013). Efficacy of social cognition remediation programs targeting facial affect recognition deficits in schizophrenia: a review and consideration of high-risk samples and sex differences. Psychiatry Res 206: 125-139.
40. Striepens N, Kendrick KM, Hanking V, Landgraf R, Wullner U, Maier W et al (2013). Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Scientific reports 3: 3440.
41. Zaki J, Ochsner K (2011). Reintegrating the study of accuracy into social cognition research. Psychol Inq 22: 159-182.
42. Zaki J, Weber J, Bolger N, Ochsner K (2009). The neural bases of empathic accuracy. Proc Natl Acad Sci USA 106: 11382-11387.